Champions Oncology, Inc. (CSBR) Social Stream
CHAMPIONS ONCOLOGY INC (CSBR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CSBR.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-15 | 1 | $16 | $16 | $16 | $4.15 | 285.54% |
| 2022-03-22 | 1 | $13 | $13 | $13 | $4.15 | 213.25% |
| 2022-04-14 | 2 | $14 | $13 | $13.5 | $4.15 | 225.3% |
| 2022-08-01 | 2 | $16 | $14 | $15 | $4.15 | 261.45% |
| 2022-09-21 | 2 | $15 | $14 | $14.5 | $4.15 | 249.4% |
| 2023-01-19 | 2 | $14 | $9 | $11.5 | $4.15 | 177.11% |
| 2023-03-20 | 2 | $14 | $9 | $11.5 | $4.15 | 177.11% |
Price Target Last Issued December 15, 2021
The Trend in the Analyst Price Target
CSBR's average price target has moved down $3.5 over the prior 21 months.
Over the past 49 weeks, CSBR's average upside potential has been 109.2%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-14 | 2 | 14 | 13 | 13.5 | 8.26 | 63.44% |
| 2022-08-01 | 2 | 16 | 14 | 15.0 | 8.84 | 69.68% |
| 2022-09-21 | 2 | 15 | 14 | 14.5 | 8.77 | 65.34% |
| 2023-01-19 | 2 | 14 | 9 | 11.5 | 4.41 | 160.77% |
| 2023-03-20 | 2 | 14 | 9 | 11.5 | 4.01 | 186.78% |
CSBR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 1 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 15 months, CSBR's average broker recommendation rating worsened by 1.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, CHAMPIONS ONCOLOGY INC's number of analysts covering the stock is higher than 13.12% of them.
- In terms of how CHAMPIONS ONCOLOGY INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 47.06% of that group.
- CSBR has a greater average analyst price target than 182.49% of Healthcare stocks.
- CSBR has a greater upside potential (average analyst target price relative to current price) than 437.34% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CHAMPIONS ONCOLOGY INC are CDTX, TARA, and TCON.
View All Top Stocks by Price Target
Is CSBR a Buy, Hold or Sell? See the POWR Ratings now!